Role of HOMA-IR and IL-6 as screening markers for the metabolic syndrome in patients with chronic schizophrenia: a psychiatric hospital-based cross-sectional study.

Yuan, Xiaoping; Yang, Qiongyao; Yao, Yitan; Song, Suqi; Zhou, Xiaoqin; Liu, Huanzhong; Zhang, Kai

Yuan, Xiaoping; Yang, Qiongyao; Yao, Yitan; Song, Suqi; Zhou, Xiaoqin; Liu, Huanzhong; Zhang, Kai.

Afiliação

Yuan X; Department of Psychiatry, Chaohu Hospital of Anhui Medical University, 64 North Chaohu Road, Hefei, 238000, China.
Yang Q; Anhui Psychiatric Center, Anhui Medical University, Hefei, China.
Yao Y; Department of Psychiatry, Chaohu Hospital of Anhui Medical University, 64 North Chaohu Road, Hefei, 238000, China.
Song S; Anhui Psychiatric Center, Anhui Medical University, Hefei, China.
Zhou X; School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, China.
Liu H; Department of Psychiatry, Chaohu Hospital of Anhui Medical University, 64 North Chaohu Road, Hefei, 238000, China.
Zhang K; Anhui Psychiatric Center, Anhui Medical University, Hefei, China.

Eur Arch Psychiatry Clin Neurosci ; 2023 May 11.

Article em En | MEDLINE | ID: mdl-37166483

Palavras-chave

Cytokine; HOMA-IR; IL-6; Metabolic syndrome; Schizophrenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Eur Arch Psychiatry Clin Neurosci Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google